A fourth class of anti-dysrhythmic action? Effect of verapamil on ouabain toxicity, on atrial and ventricular intracellular potentials, and on other features of cardiac function.
D000200:Action Potentials / Q000187:drug effects; D000772:Anesthesia, Local; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000145:classification*; D001001:Anura; D001145:Arrhythmias, Cardiac / Q000517:prevention & control; D002118:Calcium / Q000378:metabolism; D004553:Electric Conductivity / Q000187:drug effects; D004562:Electrocardiography; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D010042:Ouabain / Q000037:antagonists & inhibitors*; D011817:Rabbits; D012584:Sciatic Nerve / Q000187:drug effects; D014700:Verapamil / Q000494:pharmacology*
D000889:Anti-Arrhythmia Agents; D010042:Ouabain; D014700:Verapamil; D002118:Calcium